Clinical Trial Update: SYS6010 Versus Chemotherapy in Locally Advanced or Metastatic/Recurrent Esophageal Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Clinical trial comparing SYS6010 against chemotherapy in locally advanced or metastatic/recurrent esophageal squamous cell carcinoma; the study is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• SYS6010

Snippet

Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. | Conditions: Locally Advanced/Metastatic/Recurrent ESCC | Phase 3 | Status: NOT_YET_RECRUITING